Doximity Reports Q4 2025 Results

Healthcare networking platform Doximity (NYSE:DOCS) announced its Q4 2025 results, showing a 9.8% year-over-year revenue increase to $185.1 million, surpassing Wall Street’s earnings expectations. However, the revenue forecast for the upcoming quarter of $143.5 million fell short, being 5.2% lower than analysts had predicted. Non-GAAP earnings per share landed at $0.46, which was a 2.9% improvement over analyst estimates.

• Revenue: $185.1 million versus analyst expectations of $181.5 million (9.8% YoY growth, 2% beat)

• Adjusted EPS: $0.46 (2.9% beat) compared to the expected $0.45

• Adjusted operating profit: $109.3 million against expected $102.1 million (with a 59.1% margin, an increase of 7.1%)

• Q1 2026 Earnings Guidance: Midpoint sales projected at $143.5 million, below analysts’ $151.3 million

• Full-year EBITDA outlook: Midpoint at $356 million, aligning with analyst predictions

• Operating profit margin: 38.9%, down from 47.4% in the same quarter last year

• Free cash flow margin: 31.6%, a drop from 54.3% in the previous quarter

• Market capitalization: $6.64 billion

With over 80% of U.S. physicians part of digital communities, Doximity provides a platform for healthcare professionals to connect, access medical news, manage careers, and conduct virtual consultations. The company’s long-term performance serves as a key indicator of its quality. While short-term victories can happen, the best firms typically enjoy extended periods of growth. Doximity has shown impressive compound annual growth, at 29.3% over the last five years, which is noteworthy as it exceeds the average growth seen in other software companies.

For its recent quarter, Doximity achieved a 9.8% increase in revenue, reaching $185.1 million, which was slightly higher than what Wall Street had anticipated. However, management is targeting a modest 3.8% year-over-year increase in sales for next quarter. Analysts see a projected 9% sales growth over the next year, which is slowing compared to prior years and may suggest potential demand issues for its offerings, although other financial health indicators remain strong.

When examining a company’s future, it’s essential to consider factors like customer acquisition costs (CAC) and how quickly they recover investments in sales and marketing. Doximity reported a CAC payback period of 6.4 months, indicating efficiency in acquiring new customers. This strong performance suggests the company has a solid product, allowing for resources to explore new initiatives while still investing in marketing.

While there were positive outcomes with earnings and EBITDA beating expectations, the decline in revenue guidance raised concerns. Following the announcement, Doximity’s stock dropped 32.5% to $22.50. But one earnings report shouldn’t solely determine a company’s value; broader factors like overall valuation and business quality should inform any investment decisions.